: Cargo Therapeutics rises 2.2% in trading debut after IPO priced at low end of range
The stock of Cargo Therapeutics, a clinical-stage biotech, rose in its trading debut Friday.
The stock of Cargo Therapeutics, a clinical-stage biotech, rose in its trading debut Friday.